1. Home
  2. NXPL vs FEMY Comparison

NXPL vs FEMY Comparison

Compare NXPL & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPL
  • FEMY
  • Stock Information
  • Founded
  • NXPL 1997
  • FEMY 2004
  • Country
  • NXPL United States
  • FEMY United States
  • Employees
  • NXPL N/A
  • FEMY N/A
  • Industry
  • NXPL Telecommunications Equipment
  • FEMY Medical/Dental Instruments
  • Sector
  • NXPL Telecommunications
  • FEMY Health Care
  • Exchange
  • NXPL Nasdaq
  • FEMY Nasdaq
  • Market Cap
  • NXPL 25.6M
  • FEMY 30.2M
  • IPO Year
  • NXPL N/A
  • FEMY 2021
  • Fundamental
  • Price
  • NXPL $0.81
  • FEMY $0.80
  • Analyst Decision
  • NXPL
  • FEMY Strong Buy
  • Analyst Count
  • NXPL 0
  • FEMY 3
  • Target Price
  • NXPL N/A
  • FEMY $7.33
  • AVG Volume (30 Days)
  • NXPL 1.7M
  • FEMY 14.2M
  • Earning Date
  • NXPL 11-13-2025
  • FEMY 11-10-2025
  • Dividend Yield
  • NXPL N/A
  • FEMY N/A
  • EPS Growth
  • NXPL N/A
  • FEMY N/A
  • EPS
  • NXPL N/A
  • FEMY N/A
  • Revenue
  • NXPL $58,766,000.00
  • FEMY $1,887,016.00
  • Revenue This Year
  • NXPL N/A
  • FEMY $103.55
  • Revenue Next Year
  • NXPL N/A
  • FEMY $148.13
  • P/E Ratio
  • NXPL N/A
  • FEMY N/A
  • Revenue Growth
  • NXPL N/A
  • FEMY 98.61
  • 52 Week Low
  • NXPL $0.43
  • FEMY $0.31
  • 52 Week High
  • NXPL $2.30
  • FEMY $1.80
  • Technical
  • Relative Strength Index (RSI)
  • NXPL 48.78
  • FEMY 59.97
  • Support Level
  • NXPL $0.78
  • FEMY $0.61
  • Resistance Level
  • NXPL $0.88
  • FEMY $0.88
  • Average True Range (ATR)
  • NXPL 0.09
  • FEMY 0.11
  • MACD
  • NXPL 0.00
  • FEMY 0.01
  • Stochastic Oscillator
  • NXPL 24.20
  • FEMY 61.06

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: